Expanded access offered for drug to boost platelets
NCT ID NCT04837703
Summary
This program provides access to the drug eltrombopag for patients with medically significant low platelet counts (thrombocytopenia) who meet specific eligibility criteria. It is for patients with certain conditions like chronic immune thrombocytopenia (ITP), severe aplastic anemia, or hepatitis C, who have tried other treatments or have no good alternatives. The goal is to help increase platelet counts and manage the condition under a doctor's care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.